Published in J Med Virol on February 01, 1985
Recombination in the genesis and evolution of hepatitis B virus genotypes. J Virol (2005) 2.24
Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas. Epidemiol Infect (1996) 1.42
The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: a view from tropical and subtropical Africa. Gut (1996) 1.32
Hepatitis A, B and C viral co-infections among HIV-infected adults presenting for care and treatment at Muhimbili National Hospital in Dar es Salaam, Tanzania. BMC Public Health (2008) 1.05
Isolation of an E. coli strain with a mutation affecting DNA polymerase. Nature (1969) 12.96
Mutation selection and the natural history of cancer. Nature (1975) 9.73
A new pathway for DNA repair in Escherichia coli. Nature (1977) 5.37
Slim disease: a new disease in Uganda and its association with HTLV-III infection. Lancet (1985) 4.99
Antibody to hepatitis-B-virus core in man. Lancet (1973) 4.24
Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer. Cancer Res (1989) 3.35
The origin of human cancers. Nature (1981) 3.24
The segregation of DNA in epithelial stem cells. Cell (1978) 3.12
Mechanisms of directed mutation. Genetics (1992) 2.92
The developing role of ecotoxicology in industrial ecology and natural capitalism. Environ Health Perspect (2000) 2.60
The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation. Health Technol Assess (2007) 2.27
Aggressive Kaposi's sarcoma in Zambia, 1983. Lancet (1984) 2.15
How should results from completed studies influence ongoing clinical trials? The CAFA Study experience. Ann Intern Med (1991) 2.06
Inhibition by desferrioxamine of in-vitro replication of HIV-1. Lancet (1991) 2.05
Antibody to hepatitis B core antigen. A sensitive indicator of hepatitis B virus replication. N Engl J Med (1974) 1.98
Viral hepatitis, type B, DNA polymerase activity and antibody to hepatitis B core antigen. N Engl J Med (1974) 1.92
Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989. Pediatrics (1991) 1.86
Transmission of non-A, non-B hepatitis from man to chimpanzee. Lancet (1978) 1.82
Climate change and the integrity of science. Science (2010) 1.80
Quantitation of the adaptive response to alkylating agents. Nature (1979) 1.80
Depression and risk of sudden cardiac death after acute myocardial infarction: testing for the confounding effects of fatigue. Psychosom Med (2000) 1.80
The costs of prevention. BMJ (1995) 1.66
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess (2013) 1.66
Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer. Br J Cancer (1992) 1.62
Hepatitis B infection in households of chronic carriers of hepatitis B surface antigen: factors associated with prevalence of infection. Am J Epidemiol (1982) 1.60
Sporadic non-A, non-B hepatitis: frequency and epidemiology in an urban U.S. population. J Infect Dis (1982) 1.59
Prevalence of overweight and obesity in East and West German children in the decade after reunification: population-based series of cross-sectional studies. J Epidemiol Community Health (2008) 1.56
Hepatitis B virus infection in chimpanzees: titration of subtypes. J Infect Dis (1975) 1.55
Timing of the steps in transformation of C3H 10T 1/2 cells by X-irradiation. Nature (1984) 1.54
Random components in mutagenesis. Nature (1982) 1.53
Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study. Cancer (1990) 1.52
Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet. J Natl Cancer Inst (1992) 1.51
Directed mutation. Science (1993) 1.51
Hepatitis A antigen particles in liver, bile, and stool of chimpanzees. J Infect Dis (1976) 1.51
The inducible repair of alkylated DNA. Prog Nucleic Acid Res Mol Biol (1981) 1.51
Measuring health outcomes. BMJ (1996) 1.49
Training doctors and surgeons to meet the surgical needs of Africa. Br Med J (Clin Res Ed) (1987) 1.46
Effect of 32P decay upon DNA synthesis by a radiation-sensitive strain of Escherichia coli. J Mol Biol (1966) 1.46
The cancer problem. Sci Am (1975) 1.46
Pathways of mutagenesis and repair in Escherichia coli exposed to low levels of simple alkylating agents. J Bacteriol (1978) 1.43
Autoradiography of HeLa cell DNA. J Mol Biol (1966) 1.41
Plasma derivatives and viral hepatitis. Transfusion (1982) 1.40
Transmission of hepatitis B by immune serum globulin. Lancet (1979) 1.40
Poor adherence to placebo or amiodarone therapy predicts mortality: results from the CAMIAT study. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial. Psychosom Med (1999) 1.40
Establishing patient preferences for blood transfusion support: an application of conjoint analysis. J Health Serv Res Policy (1998) 1.38
Buruli ulcer in Ghana. Br Med J (1971) 1.38
Did HIV and HTLV originate in Africa? JAMA (1990) 1.38
A randomised controlled trial of postoperative radiotherapy following breast-conserving surgery in a minimum-risk older population. The PRIME trial. Health Technol Assess (2007) 1.34
Subtyping of hepatitis B surface antigen and antibody by radioimmunoassay. Gastroenterology (1977) 1.34
Protection against hepatitis B virus infection by immunization with hepatitis B core antigen. Gastroenterology (1985) 1.32
Polysaccharide in delayed hypersensitivity. I. Pneumococcal polysaccharide as inducer and elicitor of delayed reactivity in guinea pigs. J Exp Med (1970) 1.30
Hepatitis B core antigen: immunology and electron microscopy. J Virol (1974) 1.30
Vascularization of small hepatocellular carcinomas: correlation with differentiation. Liver (1999) 1.29
Transmission of tick-borne agents of disease by blood transfusion: a review of known and potential risks in the United States. Transfusion (2000) 1.29
Hepatitis B and primary hepatocellular carcinoma in a European population. Lancet (1978) 1.27
Localization of hepatitis A antigen in marmoset organs during acute infection with hepatitis A virus. J Infect Dis (1978) 1.26
Effect of cyanide and carbon monoxide on the replication of bacterial DNA in vivo. J Mol Biol (1968) 1.26
HTLV-III serology distinguishes atypical and endemic Kaposi's sarcoma in Africa. Lancet (1985) 1.25
Transmission of non-A, non-B hepatitis. Ann Intern Med (1977) 1.25
Effect of ethanol during hepatitis B virus infection in chimpanzees. J Med Virol (1978) 1.24
The occurrence of heritable Mu excisions in starving cells of Escherichia coli. EMBO J (1994) 1.20
Genetically Engineered Erwinia carotovora: Survival, Intraspecific Competition, and Effects upon Selected Bacterial Genera. Appl Environ Microbiol (1990) 1.20
The three viruses of non-A, non-B hepatitis. Lancet (1985) 1.18
Newly licensed hepatitis B vaccine. Known safety and unknown risks. JAMA (1983) 1.16
Macular-foveal capillaries in human retina. Aust J Ophthalmol (1973) 1.16
Patient weighting of importance of asthma symptoms. Thorax (2001) 1.16
Inactivation of a redox-sensitive protein phosphatase during the early events of tumor necrosis factor/interleukin-1 signal transduction. J Biol Chem (1993) 1.16
Genetically Engineered Erwinia carotovora in Aquatic Microcosms: Survival and Effects on Functional Groups of Indigenous Bacteria. Appl Environ Microbiol (1989) 1.13
Immunofluorescence microscopy in experimentally induced, type B hepatitis in the chimpanzee. Gastroenterology (1978) 1.13
African Kaposi's sarcoma and AIDS. Lancet (1984) 1.12
Hot-spot mutations in hepatitis B virus X gene in hepatocellular carcinoma. Lancet (1996) 1.12
A sequence in HpaI-P fragment of herpes simplex virus-1 DNA determines intraperitoneal virulence in mice. Virology (1986) 1.12
Comparative trial of influenza vaccines. II. Adverse reactions in children and adults. Am J Epidemiol (1976) 1.11
Acute non-A, non-B hepatitis: specific ultrastructural alterations in endoplasmic reticulum of infected hepatocytes. Lancet (1979) 1.10
Hepatitis B virus infection and primary hepatocellular carcinoma. J Natl Cancer Inst (1977) 1.10
Alphafetoprotein levels of liver cancer patients and controls in a European population. Cancer (1980) 1.09
Use of and interpretation of results using inocula of hepatitis B virus with known infectivity titers. J Infect Dis (1983) 1.08
A phase II study of adriamycin (NSC 123127) in patients with hepatocellular carcinoma from Zambia and the United States. Cancer (1977) 1.08
Efficiency of the adaptive response of Escherichia coli to alkylating agents. Nature (1980) 1.04
The mysterious steps in carcinogenesis. Br J Cancer (2009) 1.04
Viral hepatitis type B during pregnancy, the neonatal period, and infancy. J Pediatr (1977) 1.04
What is the best imaging strategy for acute stroke? Health Technol Assess (2004) 1.04
New findings in live, attenuated hepatitis A vaccine development. J Med Virol (1986) 1.04
Nine-year follow-up study of a plasma-derived hepatitis B vaccine in a rural African setting. J Med Virol (1993) 1.03